{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:23Z","timestamp":1786119383790,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/mot.0b013e32832e6f7b","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T03:18:20Z","timestamp":1253071100000},"page":"566-570","source":"Crossref","is-referenced-by-count":11,"title":["Renal-sparing strategies in cardiac transplantation"],"prefix":"10.1097","volume":"14","author":[{"given":"Finn","family":"Gustafsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210206","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.healun.2008.06.017","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008","volume":"27","author":"Taylor","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R2-21-20210206","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.healun.2005.07.011","article-title":"Peri-operative renal function and outcome after orthotopic heart transplantation","volume":"25","author":"Odim","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R3-21-20210206","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-6143.2006.01640.x","article-title":"The outcome of heart transplant recipients following the development of end-stage renal disease: analysis of the Canadian Organ Replacement Register (CORR)","volume":"7","author":"Alam","year":"2007","journal-title":"Am J Transplant"},{"key":"R4-21-20210206","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1016\/j.transproceed.2004.01.011","article-title":"Nephrotoxic aspects of cyclosporine","volume":"36","author":"Cattaneo","year":"2004","journal-title":"Transplant Proc"},{"key":"R5-21-20210206","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"R6-21-20210206","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.healun.2004.08.003","article-title":"Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation","volume":"24","author":"Rosenberg","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R7-21-20210206","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.TP.0000130179.18176.3D","article-title":"Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction","volume":"78","author":"Cantarovich","year":"2004","journal-title":"Transplantation"},{"key":"R8-21-20210206","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.healun.2008.05.013","article-title":"Interleukin-2 receptor antagonists as induction therapy after heart transplantation: systematic review with meta-analysis of randomized trials","volume":"27","author":"Moller","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R9-21-20210206","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2003.09.043","article-title":"Use of basiliximab and cyclosporine in heart transplant patients with preoperative renal dysfunction","volume":"24","author":"Delgado","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R10-21-20210206","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/01.tp.0000253883.52525.7c","article-title":"Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients","volume":"83","author":"Hamour","year":"2007","journal-title":"Transplantation"},{"key":"R11-21-20210206","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1399-0012.2005.00238.x","article-title":"Heart transplant recipient clinical profile improvement following mycophenolate mofetil late incorporation into the treatment schedule","volume":"19","author":"Manito","year":"2005","journal-title":"Clin Transplant"},{"key":"R12-21-20210206","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1053-2498(00)00296-5","article-title":"Benefit of mycophenolate-mofetil (MMF) in patients with cyclosporine (CYA) induced nephropathy after cardiac transplantation","volume":"20","author":"Zuckermann","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R13-21-20210206","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.ehj.2004.06.032","article-title":"Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients: the IMPROVED multicentre study","volume":"25","author":"Angermann","year":"2004","journal-title":"Eur Heart J"},{"key":"R14-21-20210206","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"R15-21-20210206","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"R16-21-20210206","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.healun.2007.03.011","article-title":"Low-dose tacrolimus\/sirolimus and steroid withdrawal in heart recipients is highly efficacious","volume":"26","author":"Meiser","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R17-21-20210206","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.healun.2007.02.008","article-title":"Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients","volume":"26","author":"Lehmkuhl","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R18-21-20210206","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.healun.2007.11.565","article-title":"Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients","volume":"27","author":"Ross","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R19-21-20210206","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trim.2006.02.001","article-title":"Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients","volume":"16","author":"Schweiger","year":"2006","journal-title":"Transpl Immunol"},{"key":"R20-21-20210206","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2004-820880","article-title":"First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation","volume":"52","author":"Trosch","year":"2004","journal-title":"Thorac Cardiovasc Surg"},{"key":"R21-21-20210206","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/j.healun.2006.11.419","article-title":"Premature termination of a prospective, open-label, randomized, multicentre trial of Srl to replace CNIs in a standard care regimen of CNI, MMF and corticosteroids early after heart transplantation [abstract]","volume":"26","author":"Hunt","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R22-21-20210206","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.healun.2005.02.018","article-title":"Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation","volume":"24","author":"Hunt","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R23-21-20210206","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.transproceed.2006.08.075","article-title":"Sirolimus experience in heart transplantation","volume":"38","author":"Aranda-Dios","year":"2006","journal-title":"Transplant Proc"},{"key":"R24-21-20210206","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.tp.0000177644.45192.a3","article-title":"Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up","volume":"81","author":"Bestetti","year":"2006","journal-title":"Transplantation"},{"key":"R25-21-20210206","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.healun.2007.01.017","article-title":"Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up","volume":"26","author":"Rothenburger","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R26-21-20210206","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.tp.0000276959.56959.69","article-title":"Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients","volume":"84","author":"Raichlin","year":"2007","journal-title":"Transplantation"},{"key":"R27-21-20210206","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S1053-2498(01)00421-1","article-title":"Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment","volume":"21","author":"Snell","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R28-21-20210206","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.TP.0000103740.98095.14","article-title":"Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure","volume":"77","author":"Groetzner","year":"2004","journal-title":"Transplantation"},{"key":"R29-21-20210206","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.healun.2005.08.015","article-title":"Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity","volume":"24","author":"Kushwaha","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R30-21-20210206","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/j.1600-6143.2006.01527.x","article-title":"Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapy","volume":"6","author":"Gleissner","year":"2006","journal-title":"Am J Transplant"},{"key":"R31-21-20210206","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-0012.2006.00632.x","article-title":"Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients","volume":"21","author":"Potter","year":"2007","journal-title":"Clin Transplant"},{"key":"R32-21-20210206","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/TP.0b013e3181963371","article-title":"Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure","volume":"87","author":"Groetzner","year":"2009","journal-title":"Transplantation"},{"key":"R33-21-20210206","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2007.07.034","article-title":"Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction","volume":"26","author":"Gustafsson","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R34-21-20210206","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1600-6143.2007.02142.x","article-title":"Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients","volume":"8","author":"Aliabadi","year":"2008","journal-title":"Am J Transplant"},{"key":"R35-21-20210206","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1600-6143.2005.00757.x","article-title":"First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation","volume":"5","author":"Meiser","year":"2005","journal-title":"Am J Transplant"},{"key":"R36-21-20210206","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1016\/j.transproceed.2005.09.152","article-title":"Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center","volume":"37","author":"Fernandez-Valls","year":"2005","journal-title":"Transplant Proc"},{"key":"R37-21-20210206","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-6143.2008.02456.x","article-title":"Outcomes following de novo CNI-free immunosuppression after heart transplantation: a single-center experience","volume":"9","author":"Leet","year":"2009","journal-title":"Am J Transplant"},{"key":"R38-21-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ftd.0000159786.10625.85","article-title":"Cyclosporine monitoring with 2-h postdose levels in heart transplant recipients","volume":"27","author":"Solari","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R39-21-20210206","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-0012.1998.tb01098.x","article-title":"Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy","volume":"12","author":"Cantarovich","year":"1998","journal-title":"Clin Transplant"},{"key":"R40-21-20210206","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.healun.2004.08.002","article-title":"Monitoring of cyclosporine 2-h postdose levels in heart transplantation: improvement in clinical outcomes","volume":"24","author":"Delgado","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R41-21-20210206","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/TP.0b013e318169bf43","article-title":"Benefit of Neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction","volume":"85","author":"Cantarovich","year":"2008","journal-title":"Transplantation"},{"key":"R42-21-20210206","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.healun.2005.11.251","article-title":"De novo C2 monitoring immediately after cardiac transplantation is not associated with improved renal function (abstract)","volume":"25","author":"Kittleson","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R43-21-20210206","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.healun.2005.04.019","article-title":"A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients","volume":"24","author":"Mathias","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R44-21-20210206","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00007890-199912270-00003","article-title":"Clinical benefit of neoral dose monitoring with cyclosporine 2-hr postdose levels compared with trough levels in stable heart transplant patients","volume":"68","author":"Cantarovich","year":"1999","journal-title":"Transplantation"},{"key":"R45-21-20210206","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/01.HYP.33.3.862","article-title":"ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients","volume":"33","author":"Hausberg","year":"1999","journal-title":"Hypertension"},{"key":"R46-21-20210206","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00007890-200112150-00013","article-title":"Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOT.0b013e32832e6f7b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:02:01Z","timestamp":1786039321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00075200-200910000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e32832e6f7b","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}